最新消息 生華科首度於AACR年會設展區 深化國際交流布局商機 Apr 03 2024 最新消息 生華科社區型肺炎臨床收首位病人 同步開發次世代新藥精準投藥 Mar 20 2024 最新消息 生華科獲TFDA核准社區型肺炎臨床 明一月疫情高峰將加速收案 Dec 25 2023 媒體報導 生華科狙殺多達8種癌症兩新藥 首進美國癌症研究協會年會找商機 Apr 03 2024 媒體報導 疫情升溫 生華科料將加速收案 Dec 26 2023 媒體報導 生華科(6492)新冠藥Silmitasertib(CX-4945)創新布局染疫後免疫及蹦領域完成首位病人收案 Nov 09 2023 期刊 Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study Sep 24 2022 期刊 Protein kinase CK2: a potential therapeutic target for diverse human diseases Jul 20 2021 期刊 Silmitasertib (CX-4945) in combination with gemcitabine and cisplatin as first-line treatment for patients with locally advanced or metastatic cholangiocarcinoma: A phase Ib/II study. Jan 12 2021